Chasing the cabotegravir tail: implications for prevention

Lancet HIV. 2020 Jul;7(7):e451-e453. doi: 10.1016/S2352-3018(20)30165-X. Epub 2020 Jun 1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-HIV Agents*
  • HIV Infections*
  • Humans
  • Pyridones

Substances

  • Anti-HIV Agents
  • Pyridones
  • cabotegravir

Associated data

  • ClinicalTrials.gov/NCT02720094
  • ClinicalTrials.gov/NCT03164564